Clinical Trial of BE-CAR7 Achieves 82% Remission BE-CAR7 treatment shows 82% remission for T-cell leukaemia. Two-thirds of patients are disease-free after trial. Alyssa Tapley was first patient treated and thanked the trial. Medicine | Clinical Trials | Cancer Research Dr Tania Dexter | Alyssa Tapley 1 month ago